Archer Materials Limited · ASX:AXE

Archer Materials — Semiconductor Australia 2025

19 slides from Archer Materials's conference presentation, Oct 22, 2025

  1. Slide 1: Presentation – Semiconductor Australia 2025

    Archer Materials Archer Materials Limited (ACN: 123 993 233) Technology Lot Fourteen, Frome Road, Adelaide SA 5000 www.archerx.com.au ASX Announcement (ASX: AXE) 22 October 2025 Presentation – Semiconductor Australia 2025 Archer Materials Limited (“Archer”, the “Company”, “ASX: AXE”) is pleased to e

  2. Slide 2: Semiconductor Australia 2025

    For personal use only Semiconductor Australia 2025 22 October 2025

  3. Slide 3: Overview

    For personal use only Overview 01

  4. Slide 4: About Archer: Our Technology

    ABOUT ARCHER Our Technology Archer Materials is the only ASX-listed quantum technologies company. We are developing products to address high-value problems in computing, sensing, and medical markets. For personal use only 12CQ Chip A carbon-based Qubit demo quantum 1HCY26 Advanced device for applica

  5. Slide 5: Key Catalysts and Outlook

    Key Catalysts and ‣ Lab demonstrator of blood potassium Outlook sensor end of 2025 For personal use only ‣ Blood potassium prototype sensor mid- Calendar years to 2027 2026 Early demo of next gen biochip applications ‣ End of 2026 begin clinical trials for blood Biochip lab Biochip prototype Biochip

  6. Slide 6: Archer's Carbon Quantum – differentiation & advantages

    QUANTUM COMPUTING Archer’s Carbon Quantum – differentiation & advantages For personal use only ▪ Our differentiated approach is aimed at tackling current quantum technology roadblocks like manufacturability, scaling, cost, and complexity. ▪ Our purpose is to commercialise quantum innovation in ways

  7. Slide 7: Quantum Technology: The Next Frontier

    QUANTUM COMPUTING Quantum Technology: Quantum Technology Market Growth The Next Frontier For personal use only Projections 2025-2040 Archer considers quantum technology to be the next great technological advance. ‣ Archer is the only ASX-listed quantum company. ‣ Adoption of quantum tech expected to

  8. Slide 8: BioChip

    For personal use only BioChip 02

  9. Slide 9: Biochip: High-Value Problem

    BIOCHIP ‣ Over 850M people (>10% of global High-Value Problem population) suffer from chronic kidney disease (CKD). For personal use only Archer’s biochip uses highly sensitive, high speed, low power ‣ More than US$3B total addressable market sensors to detect ions in blood. The chip will be integra

  10. Slide 10: Biochip Value Proposition (US Medicare Population)

    BIOCHIP Value Proposition (US Medicare Population) Cost per year per patient ($) For personal use only 40,000 ▪ The Problem: CKD patients with hyperkalemia drive $34,363 billions in preventable costs (>$15k per patient, >$30B total). 20,000 ▪ The Gap: No convenient, fast, low-cost potassium $15,013

  11. Slide 11: Our Solution: Archer Potassium Test

    BIOCHIP Our Solution: Archer Potassium Test The first of its kind and the most technologically advanced For personal use only Built to prevent life-threatening cardiac events. POC medical diagnostic in the world. ▪ A technology inflection beyond decades-old lateral flow tests. ▪ More capability and

  12. Slide 12: At-home Potassium Sensor - Roadmap

    BIOCHIP At-home Potassium Sensor - Roadmap For personal use only Phase gate development process for a diagnostic medical device regulated under ISO13485 Scale up & Development & Verification & Proof of concept Feasibility transfer to Launch Optimisation validation manufacturing 2025 • Work ramping u

  13. Slide 13: Quantum Computing and Sensing

    Quantum Computing and Sensing For personal use only 03

  14. Slide 14: Qubit Roadmap

    QUANTUM COMPUTING Qubit Roadmap For personal use only Work will be extended on devices built around nanodots of carbon. Targeting a qubit architecture demonstration in 2026. Demonstration of Electron spin state readout – Full qubit gating in Archer’s Detection of Zeeman split spin demonstration prop

  15. Slide 15: Key Partnerships

    PARTNERS Key Partnerships For personal use only Key for biochip Paragraf is one of the Partnering to integrate EPFL have been a long- We’re harnessing productization and world’s only dedicated their homolysis sensor time partner and have graphene and carbon- derisking various aspects graphene foundr

  16. Slide 16: Thank you

    Thank you For personal use only ASX Code: AXE Sydney Adelaide Website The Board of Archer authorised this Level 2, 477 Pitt St Lot Fourteen, Frome Rd www.archerx.com.au announcement to be given to ASX. Sydney NSW 2000 Adelaide SA 5000 Archer Materials Limited ABN 64 123 993 233 www.archerx.com.au

  17. Slide 17: Disclaimer

    Disclaimer The material contained in this document is a presentation of general information about the activities of Archer Materials Ltd and its related bodies For personal use only corporate (together the “Archer Group”), current as at the date of this presentation. It is provided in summary and do

  18. Slide 18: About Archer: Corporate Snapshot

    ABOUT ARCHER ASX Code: AXE Corporate 255m $0.27 For personal use only Snapshot Shares on issue Share price (9 Sep 2025) Founded in 2007, Archer Materials (ASX:AXE) is developing unique semiconductor technology to solve critical problems in quantum tech and bio $70m Nil electronics, helping unlock tr

  19. Slide 19: Archer Future technologies

    ARCHER Future technologies Archer’s devices look to solve high value problems using quantum technology. Our For personal use only Foundations Strong partnerships Strong industry partnerships and links with leading research institutes. Archer has the foundations in place to advance its quantum techno

Archer Materials — Semiconductor Australia 2025 on 6ix